These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2436000)

  • 1. Acute hemodynamic effects of MDL 19205 in mild congestive heart failure.
    Cottier C; Follath F; Kiowski W; Pfisterer M; Emmenegger H; Burkart F
    J Cardiovasc Pharmacol; 1987 Feb; 9(2):209-12. PubMed ID: 2436000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positive inotropic and vasodilator effects of MDL 17,043 in patients with reduced left ventricular performance.
    Crawford MH; Richards KL; Sodums MT; Kennedy GT
    Am J Cardiol; 1984 Apr; 53(8):1051-3. PubMed ID: 6230926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a new cardiotonic agent, MDL-17,043, on myocardial contractility and left ventricular performance in congestive heart failure.
    Strain J; Grose R; Maskin CS; LeJemtel TH
    Am Heart J; 1985 Jul; 110(1 Pt 1):91-6. PubMed ID: 3160228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positive inotropic therapy for short-term support and long-term management of patients with congestive heart failure: hemodynamic effects and clinical efficacy of MDL 17,043.
    Uretsky BF; Valdes AM; Reddy PS
    Circulation; 1986 Mar; 73(3 Pt 2):III219-29. PubMed ID: 2935328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MDL 17,043 therapy in severe congestive heart failure: characterization of the early and late hemodynamic, pharmacokinetic, hormonal and clinical response.
    Uretsky BF; Generalovich T; Verbalis JG; Valdes AM; Reddy PS
    J Am Coll Cardiol; 1985 Jun; 5(6):1414-21. PubMed ID: 3158689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic effects of MDL 17,043, a new cardiotonic agent, in patients with congestive heart failure: comparison with sodium nitroprusside.
    Arbogast R; Brandt C; Haegele KD; Fincker JL; Schechter PJ
    J Cardiovasc Pharmacol; 1983; 5(6):998-1004. PubMed ID: 6196573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous and oral MDL 17043 (a new inotrope-vasodilator agent) in congestive heart failure: hemodynamic and clinical evaluation in 38 patients.
    Kereiakes D; Chatterjee K; Parmley WW; Atherton B; Curran D; Kereiakes A; Spangenberg R
    J Am Coll Cardiol; 1984 Nov; 4(5):884-9. PubMed ID: 6238076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute hemodynamic effect of oral MDL 17,043 in severe congestive heart failure.
    Uretsky BF; Generalovich T; Reddy PS; Salerni R; Valdes AM; Spangenberg RB; Lang JF; Okerholm RA
    Am J Cardiol; 1984 Aug; 54(3):357-62. PubMed ID: 6235735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular properties of a new cardiotonic agent: MDL 17,043 (1.3-dihydro-4-methyl-5-[4-(methylthio)-benzoyl]-2H-imidazol-2-one).
    Dage RC; Roebel LE; Hsieh CP; Weiner DL; Woodward JK
    J Cardiovasc Pharmacol; 1982; 4(3):500-8. PubMed ID: 6177949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inotropic effect of enoximone in patients with severe heart failure: demonstration by left ventricular end-systolic pressure-volume analysis.
    Herrmann HC; Ruddy TD; William G; Strauss HW; Boucher CA; Fifer MA
    J Am Coll Cardiol; 1987 May; 9(5):1117-23. PubMed ID: 2952702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement in indexes of diastolic performance in patients with congestive heart failure treated with milrinone.
    Monrad ES; McKay RG; Baim DS; Colucci WS; Fifer MA; Heller GV; Royal HD; Grossman W
    Circulation; 1984 Dec; 70(6):1030-7. PubMed ID: 6499142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamic effects of a new inotropic agent, piroximone (MDL 19205), in patients with chronic heart failure.
    Petein M; Levine TB; Cohn JN
    J Am Coll Cardiol; 1984 Aug; 4(2):364-71. PubMed ID: 6736478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in left ventricular function, coronary hemodynamics and myocardial catecholamine balance with MDL 17043, a new inotropic vasodilator agent, in patients with severe heart failure.
    Viquerat CE; Kereiakes D; Morris DL; Daly PA; Wexman M; Frank P; Parmley WW; Chatterjee K
    J Am Coll Cardiol; 1985 Feb; 5(2 Pt 1):326-32. PubMed ID: 3155761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic, neurohumoral, and myocardial energetic effects of pimobendan, a novel calcium-sensitizing compound, in patients with mild to moderate heart failure.
    Remme WJ; Kruijssen DA; van Hoogenhuyze DC; Krauss XH; Bartels GL; Storm CJ; de Leeuw PW
    J Cardiovasc Pharmacol; 1994 Nov; 24(5):730-9. PubMed ID: 7532750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative hemodynamic effects of intravenous dobutamine and MDL-17,043, a new cardioactive drug, in severe congestive heart failure.
    Amin DK; Shah PK; Shellock FG; Hulse S; Brandon G; Spangenberg R; Swan HJ
    Am Heart J; 1985 Jan; 109(1):91-8. PubMed ID: 3155585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial energetics and clinical response to the cardiotonic agent MDL 17043 in advanced heart failure.
    Martin JL; Likoff MJ; Janicki JS; Laskey WK; Hirshfeld JW; Weber KT
    J Am Coll Cardiol; 1984 Nov; 4(5):875-83. PubMed ID: 6238075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of improved left ventricular function following intravenous MDL 17,043 in patients with severe chronic heart failure.
    Kereiakes DJ; Viquerat C; Lanzer P; Botvinick EH; Spangenberg R; Buckingham M; Parmley WW; Chatterjee K
    Am Heart J; 1984 Nov; 108(5):1278-84. PubMed ID: 6238512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial metabolic and hemodynamic effects of intravenous MDL-17,043, a new cardiotonic drug, in patients with chronic severe heart failure.
    Amin DK; Shah PK; Hulse S; Shellock FG; Swan HJ
    Am Heart J; 1984 Nov; 108(5):1285-92. PubMed ID: 6238513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent hemodynamic effects without long-term clinical benefits in response to oral piroximone (MDL 19,205) in patients with congestive heart failure.
    Petein M; Levine TB; Cohn JN
    Circulation; 1986 Mar; 73(3 Pt 2):III230-6. PubMed ID: 3510778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of AR-L 115 BS on hemodynamics and contractility of the heart in cardiac patients.
    Stauch M; Nechwatal W
    Arzneimittelforschung; 1981; 31(1a):267-71. PubMed ID: 7195239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.